Related Experiment Videos

Metabolic syndrome: what might be occurring?

Harold E Bays¹

¹Louisville Metabolic and Atherosclerosis Research Center, Louisville, Ky., USA.

Managed Care (Langhorne, Pa.)

|November 17, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Oral GLP-1RA TERN-601 for Adults With Obesity/Overweight: Placebo-Controlled, Multiple-Ascending-Dose, Phase 1 and 2 Studies.

Obesity (Silver Spring, Md.)·2026

Survodutide Once Weekly for the Treatment of Adults with Obesity.

The New England journal of medicine·2026

Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.

Lancet (London, England)·2026

Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study.

Obesity (Silver Spring, Md.)·2026

Quality of life improvements associated with weight loss using a novel shape-shifting hydrogel capsule: RESET study results.

International journal of obesity (2005)·2025

Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT-MAINTAIN.

Obesity (Silver Spring, Md.)·2025

See all related articles